Zydus Lifesciences Gets USFDA Nod for Generic Parkinson's Drug
By Rediff Money Desk, New Delhi Aug 28, 2024 16:25
Zydus Lifesciences has received USFDA approval for Amantadine extended-release capsules, a generic medication for Parkinson's disease, providing 180 days of exclusivity.
![Zydus Lifesciences Gets USFDA Nod for Generic Parkinson's Drug](https://im.rediff.com/money/2012/oct/28drug.jpg)
New Delhi, Aug 28 (PTI) Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market a generic medication to treat Parkinson's disease.
The company has received approval from the US Food and Drug Administration (USFDA) to market Amantadine extended-release capsules (68.5 mg) and tentative approval for Gocovri (137 mg) capsules, the drug firm said in a statement.
Amantadine extended-release capsules are indicated for the treatment of dyskinesia in patients with Parkinson's disease.
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, Zydus Lifesciences said.
"This approval makes Zydus eligible for 180 days of exclusivity for Amantadine extended-release capsules (68.5 mg), it added.
The Gujarat-based group said it now has 400 approvals from the USFDA.
The company has received approval from the US Food and Drug Administration (USFDA) to market Amantadine extended-release capsules (68.5 mg) and tentative approval for Gocovri (137 mg) capsules, the drug firm said in a statement.
Amantadine extended-release capsules are indicated for the treatment of dyskinesia in patients with Parkinson's disease.
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, Zydus Lifesciences said.
"This approval makes Zydus eligible for 180 days of exclusivity for Amantadine extended-release capsules (68.5 mg), it added.
The Gujarat-based group said it now has 400 approvals from the USFDA.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Rajnish Wellness
- 4.94 ( -1.98)
- 60213526
- Filatex Fashions
- 1.21 (+ 4.31)
- 56554570
- Reliance Power L
- 31.28 (+ 0.58)
- 22971204
- Sakuma Exports
- 6.12 ( -4.97)
- 21799395
- NBCC (India)
- 195.90 (+ 10.27)
- 21516331
MORE NEWS
MarketsMojo Launches MOJOMF: Free Mutual Fund...
MarketsMojo introduces MOJOMF, a free mutual fund investment platform offering advisory...
![Tata Steel...](https://im.rediff.com/80-80/money/2016/may/24usd.jpg)
Tata Steel Acquires $280 Million in Singapore...
Tata Steel has acquired 178 crore equity shares in its Singapore arm TSHP for USD 280...
![Amitabh Bachchan...](https://im.rediff.com/80-80/money/2022/mar/23bachchan.jpg)
Amitabh Bachchan Family Office Invests in Swiggy
Amitabh Bachchan's family office has reportedly invested in Swiggy, buying shares from...